News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current HEMO market cap is 17.9M. The company's latest EPS is GBP -0.0035 and P/E is -4.40.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.59M | -1.46M | -2.13M | -2.66M | -5.53M |
| Net Income | -1.54M | -1.45M | -2.08M | -5.1M | -3.98M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 2.3M | 1.05M | 2.67M | 8.52M | 7.09M |
| Total Liabilities | 1.34M | 1.4M | 1.79M | 353k | 3.85M |
| Total Equity | 959k | -349k | 876k | 8.17M | 3.24M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -1.35M | -1.2M | -1.8M | -2.63M | -2.9M |
| Investing | -20k | 2k | -170k | -939k | -420k |
| Financing | 1.18M | -39k | 3.21M | 8.78M | -110k |
| Market Cap | 17.9M |
| Price to Earnings Ratio | -4.40 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 7 |
| Price to Book Ratio | 5.42 |
| Dividend Yield | - |
| Shares Outstanding | 1.14B |
| Average Volume (1 week) | 4.66M |
| Average Volume (1 Month) | 8.65M |
| 52 Week Change | -23.56% |
| 52 Week High | 6.30 |
| 52 Week Low | 1.125 |
| Spread (Intraday) | 0.06 (3.88%) |
| Company Name | Hemogenyx Pharmaceuticals Plc |
| Address |
6th floor london EC3V 0HR |
| Website | https://hemogenyx.com |
| Industry | finance services (6199) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
